FNDC5 and metabolic dysfunction-associated steatotic liver disease: Thus, we tested whether Fndc5/irisin participates in the safeguard action of NAD+-boosting molecule against NAFLD using Fndc5 knockout (Fndc5-/-) mice and further, investigated how NAD+ boosting molecule modulates Fndc5/irisin in NAFLD.